Ticker ASMBListed on Nasdaq

ASSEMBLY BIOSCIENCES, INC.

Pharmaceutical PreparationsCIK 0001426800South San Francisco, CaliforniaFilings at SEC EDGAR

At a glance

Most recent filing on November 3, 2026 — a sale by Bjorkquist Jeanette M on Nov 2, 2026.

We hold 13 Form 4 lines, going back to November 3, 2026.

5 of 13 shown

CEO pay

What the company reported for its principal executive officer, usually the CEO, in the pay-versus-performance table of its proxy statement. The total counts shares and options at their value on the day they were granted. Actually paid counts them at the change in their value during the year, so it can be far higher or lower than the total, and negative. A dash means the company reported no amount.

Jason A. Okazaki, fiscal year ended Dec 31, 2025: total $2,482,987, actually paid $5,514,184. First reported Apr 22, 2026.

Earlier fiscal years are part of the subscription.